114 related articles for article (PubMed ID: 2088853)
1. Free radical scavenging: a potentially beneficial action of thiol-containing angiotensin converting enzyme inhibitors.
Chopra M; McMurray J; Stewart J; Dargie HJ; Smith WE
Biochem Soc Trans; 1990 Dec; 18(6):1184-5. PubMed ID: 2088853
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.
Liu X; Engelman RM; Rousou JA; Cordis GA; Das DK
Cardiovasc Drugs Ther; 1992 Aug; 6(4):437-43. PubMed ID: 1387799
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors.
Chopra M; Beswick H; Clapperton M; Dargie HJ; Smith WE; McMurray J
J Cardiovasc Pharmacol; 1992 Mar; 19(3):330-40. PubMed ID: 1378110
[TBL] [Abstract][Full Text] [Related]
4. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
Westlin W; Mullane K
Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
[TBL] [Abstract][Full Text] [Related]
5. Sulfhydryl group in angiotensin converting enzyme inhibitors and superoxide radical formation.
Mehta JL; Nicolini FA; Lawson DL
J Cardiovasc Pharmacol; 1990 Nov; 16(5):847-9. PubMed ID: 1703610
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action.
Przyklenk K; Kloner RA
Am Heart J; 1991 May; 121(5):1319-30. PubMed ID: 1850188
[TBL] [Abstract][Full Text] [Related]
7. Interactions between carnosine and captopril on free radical scavenging activity and angiotensin-converting enzyme activity in vitro.
Nakagawa K; Ueno A; Nishikawa Y
Yakugaku Zasshi; 2006 Jan; 126(1):37-42. PubMed ID: 16394648
[TBL] [Abstract][Full Text] [Related]
8. Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical.
Suzuki S; Sato H; Shimada H; Takashima N; Arakawa M
Pharmacology; 1993 Jul; 47(1):61-5. PubMed ID: 8393194
[TBL] [Abstract][Full Text] [Related]
9. Free radical scavenging properties of alacepril metabolites and lisinopril.
Noda Y; Mori A; Packer L
Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):125-36. PubMed ID: 9226747
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibitors as oxygen free radical scavengers.
Mira ML; Silva MM; Queiroz MJ; Manso CF
Free Radic Res Commun; 1993; 19(3):173-81. PubMed ID: 8244086
[TBL] [Abstract][Full Text] [Related]
11. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.
Mak IT; Freedman AM; Dickens BF; Weglicki WB
Biochem Pharmacol; 1990 Nov; 40(9):2169-75. PubMed ID: 2173602
[TBL] [Abstract][Full Text] [Related]
13. [Angiotensin-converting enzyme inhibitors as neutralizers of hydroxyl radical].
Mira ML; Silva MM; Queirós MJ; Manso C
Rev Port Cardiol; 1992 May; 11(5):425-30. PubMed ID: 1325814
[TBL] [Abstract][Full Text] [Related]
14. Influence of ACE inhibitors on free radicals and reperfusion injury: pharmacological curiosity or therapeutic hope?
McMurray J; Chopra M
Br J Clin Pharmacol; 1991 Apr; 31(4):373-9. PubMed ID: 2049244
[TBL] [Abstract][Full Text] [Related]
15. Effect of .OH scavenging action by non-SH-containing angiotensin converting enzyme inhibitor imidaprilat using microdialysis.
Obata T; Yamanaka Y
J Physiol Paris; 1998 Feb; 92(1):1-4. PubMed ID: 9638590
[TBL] [Abstract][Full Text] [Related]
16. Captopril inhibits the fluorescence development associated with glycation of proteins.
Le Guen CA; Bain S; Barnett AH; Lunec J
Agents Actions; 1992 Jul; 36(3-4):264-70. PubMed ID: 1529807
[TBL] [Abstract][Full Text] [Related]
17. Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.
Ferrari R; Cargnoni A; Curello S; Ceconi C; Boraso A; Visioli O
J Cardiovasc Pharmacol; 1992; 20(5):694-704. PubMed ID: 1280730
[TBL] [Abstract][Full Text] [Related]
18. Relationships between structure and effects of ACE inhibitors: comparative effects in myocardial ischaemic/reperfusion injury.
Przyklenk K; Kloner RA
Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):167S-175S. PubMed ID: 2690907
[TBL] [Abstract][Full Text] [Related]
19. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
Anning PB; Grocott-Mason RM; Lewis MJ
Endothelium; 1997; 5(4):265-75. PubMed ID: 9588818
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury: an overview.
Zughaib ME; Sun JZ; Bolli R
Basic Res Cardiol; 1993; 88 Suppl 1():155-67. PubMed ID: 8357331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
